Abstract:Intronic deletions that critically shorten donor-to-branchpoint (D-BP) distance of a precursor mRNA impose biophysical space constraint on assembly of the U1/U2 spliceosomal complex, leading to canonical splicing failure. Here we use a series of β-globin ( HBB ) gene constructs with intron 1 deletions to define D-BP lengths that present low/no risk of mis-splicing and lengths which are critically short and likely elicit clinically relevant mis-splicing. We extend our previous observation in EMD intron 5 of 46 nt as the minimal productive D-BP length, demonstrating spliceosome assembly constraint persists at D-BP lengths of 47-56 nt. We exploit the common HBB exon 1 β-thalassemia variant that strengthens a cryptic donor (NM_000518.5(HBB):c.79G > A) to provide a simple barometer for the earliest signs of space constraint, via cryptic donor activation. For clinical evaluation of intronic deletions, we assert D-BP lengths > 60 nt present low mis-splicing risk while space constraint increases exponentially with D-BP lengths < 55 nt, with critical risk and profound splicing abnormalities with D-BP lengths < 50 nt.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is about **the impact of intron deletion - resulting in a shortened distance from donor to branch point (D - BP) - on pre - mRNA splicing**. Specifically, the researchers used β - globin gene (HBB) constructs and conducted a series of intron 1 deletion experiments to define which D - BP lengths would lead to low - risk or error - free splicing and which lengths might lead to clinically significant mis - splicing. The main purposes of the study are: 1. **Determine the minimum D - BP length**: These lengths can support the normal splicing process without causing mis - splicing. 2. **Evaluate the splicing efficiency at different D - BP lengths**: Especially when the D - BP length is less than a certain threshold, the risk of splicing failure will increase sharply. 3. **Provide clinical guidance**: Based on the experimental data, propose clinical evaluation guidelines regarding the impact of D - BP length changes after intron deletion on splicing, especially in the diagnosis of genetic diseases such as β - thalassemia. ### Research Background Pre - mRNA splicing is a crucial step in gene expression and is mainly catalyzed by large ribonucleoprotein complexes (the major spliceosome). During the splicing process, U1 and U2 small nuclear ribonucleoprotein particles (snRNPs) bind to the 5' donor splice site and the branch - point nucleotide respectively, forming a loop - like structure and bringing the donor close to the acceptor, thus facilitating the connection of two exons. Failure at any step may lead to abnormal pre - mRNA splicing, such as exon skipping, cryptic splice site activation or intron retention. ### Research Methods - **Computational prediction**: Use the Branchpointer algorithm to predict the potential branch - point positions in HBB intron 1 and determine nucleotide substitutions at each position. - **Gene construction**: Construct gene expression constructs containing HBB exons 1 - 3 and the intervening intron, and adjust the D - BP distance by deleting different parts of intron 1. - **Cell experiments**: Transfect the constructs into COS - 7 cells and analyze protein expression and splicing patterns by Western Blot and RT - PCR. - **RNA sequencing**: Perform RNA sequencing on the transfected cells to further verify the changes in splicing patterns. ### Main Findings - **The dominant branch - point in HBB intron 1**: Determine the - 37 site as the main branch - point. - **The relationship between D - BP length and splicing efficiency**: When the D - BP length is 44 - 47 nt, the splicing efficiency drops sharply; D - BP lengths below 56 nt will lead to the activation of cryptic donor sites, and further shortening the D - BP length will significantly increase the risk of mis - splicing. - **Clinical guidance**: When the D - BP length is greater than 60 nt, the risk of mis - splicing is low and can be considered benign; while when the D - BP length is less than 55 nt, the spatial constraint pressure increases sharply, resulting in severe splicing abnormalities. ### Conclusion This study, through systematic experiments and data analysis, has clarified the specific impact of intron deletion - resulting in a shortened D - BP distance - on pre - mRNA splicing, providing an important reference for clinically evaluating the impact of intron deletion on splicing. Especially for the diagnosis of genetic diseases such as β - thalassemia, these findings are of great significance.

Refining clinically relevant parameters for mis-splicing risk in shortened introns with donor-to-branchpoint space constraint

An ancient competition for the conserved branchpoint sequence influences physiological and evolutionary outcomes in splicing

Intronic Alterations Inbrca1andbrca2: Effect on Mrna Splicing Fidelity and Expression

Deep indel mutagenesis reveals the regulatory and modulatory architecture of alternative exon splicing

Experimental Assessment of Splicing Variants Using Expression Minigenes and Comparison with In Silico Predictions

Minor intron retention drives clonal hematopoietic disorders and diverse cancer predisposition

Genome-wide detection of human variants that disrupt intronic branchpoints

Functional Analysis of Variants in DMD Exon/intron 10 Predicted to Affect Splicing

Minor intron splicing revisited: identification of new minor intron-containing genes and tissue-dependent retention and alternative splicing of minor introns

Comparison of in silico strategies to prioritize rare genomic variants impacting RNA splicing for the diagnosis of genomic disorders

TP53 minigene analysis of 161 sequence changes provides evidence for role of spatial constraint and regulatory elements on variant-induced splicing impact

Genomic features defining exonic variants that modulate splicing

Prp16 enables efficient splicing of introns with diverse exonic consensus elements in the short-intron rich transcriptome

Mutation of two intronic nucleotides alters RNA structure and dynamics inhibiting MBNL1 and RBFOX1 regulated splicing of the Insulin Receptor

Experimental Tests Of Two Proofreading Mechanisms For 5 '-Splice Site Selection

Inefficient recruitment of DDX39B impedes pre-spliceosome assembly on FOXP3 introns

Spliceosomal helicases DDX41/SACY-1 and PRP22/MOG-5 both contribute to proofreading against proximal 3' splice site usage

Short amplicon reverse transcription-polymerase chain reaction detects aberrant splicing in genes with low expression in blood missed by ribonucleic acid sequencing analysis for clinical diagnosis

Splicing Analysis of Rare/novel Synonymous or Intronic Variants Identified in ABCB11 Heterozygotes Presenting As Progressive Intrahepatic Cholestasis with Low Γ‐glutamyltransferase

Expression levels of core spliceosomal proteins modulate the MBNL-mediated spliceopathy in DM1

Restriction of an intron size en route to endothermy